National Health Investors Inc (NHI)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $2.98B
Last updated: Nov 17, 2026 at 4:40 PM ET
National Health Investors Inc (NHI) Statistics
National Health Investors (NHI) has a market cap of $2.98B and a P/FFO of 12.1x on its 2026 FFO estimate. It kept 152.78% of revenue as net income over the last 12 months. Revenue grew 28.70% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 33.30% above the market cap, as debt exceeds cash.
| Market Cap | $2.98B |
|---|---|
| Enterprise Value | $3.98B |
| Latest price (Nov 17, 2026) | $60.03 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Next Ex-Dividend Date | Dec 31, 2026 |
| Next Payment Date | Jan 29, 2027 |
| Fiscal Year End | December |
Valuation Ratios
P/FFO is 12.1x on the 2026 FFO estimate of $4.96 a share. Its year-end P/S ranged from 7.6x to 11.7x from 2016 to 2025.
| P/FFO (2026 estimate) | 12.1x |
|---|---|
| Forward P/E | 16.7x |
| P/S Ratio | 6.5x |
| Forward P/S | 6.7x |
| P/B Ratio | 1.4x |
| P/OCF Ratio | 12.7x |
Enterprise Valuation
Counting debt and cash, the company is valued at 4.5x EBITDA.
| EV / Earnings | 5.7x |
|---|---|
| EV / Sales | 8.7x |
| EV / EBITDA | 4.5x |
| EV / EBIT | 5.1x |
Price Statistics
The stock is down 20.36% over 52 weeks and trades 9.82% below its 50-day average.
| Beta (1Y) | -0.22 |
|---|---|
| 52-Week Change | -20.36% |
| 1-Month Change | -7.22% |
| 3-Month Change | -17.81% |
| 6-Month Change | -19.64% |
| 5-Year Change | +24.66% |
| 10-Year Change | -11.51% |
| Total Return (1Y) | -15.45% |
| Total Return (3Y CAGR) | +7.44% |
| Total Return (5Y CAGR) | +6.00% |
| Return vs SPY (1Y) | -33.09% |
| Max Drawdown (1Y) | -32.49% |
| Max Drawdown (3Y) | -32.49% |
| Sharpe Ratio (1Y) | -0.97 |
| Correlation with SPY (1Y) | -0.12 |
| 50-Day Average | $66.57 |
| 200-Day Average | $74.44 |
| 52-Week Range | $60.53 to $88.03 |
| RSI (14 Days) | 28.5 |
| Average Volume (20 Days) | 360.37K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.51x current liabilities, and total debt is 0.50x shareholder equity.
| Current Ratio | 0.51x |
|---|---|
| Quick Ratio | 0.51x |
| Debt / Equity | 0.50x |
| Debt / EBITDA | 1.18x |
| Interest Coverage | 3.39x |
Returns and Efficiency
Return on invested capital is 19.71% over the last 12 months, against a 5-year average of 5.72%.
| Return on Equity (ROE) | 33.31% |
|---|---|
| Return on Assets (ROA) | 21.46% |
| Return on Invested Capital (ROIC) | 19.71% |
| Return on Capital Employed (ROCE) | 24.77% |
| ROE (5Y Average) | 8.51% |
| ROA (5Y Average) | 4.44% |
| ROIC (5Y Average) | 5.72% |
| Asset Turnover | 0.15x |
Taxes
Income tax took 0.15% of pretax income over the last 12 months.
| Income Tax (TTM) | $1.01M |
|---|---|
| Effective Tax Rate | 0.15% |
Scores
NHI has a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 5 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
FFO per share was $4.74 for 2025, the latest reported year. Revenue was $455.64M over the last 12 months.
| FFO Per Share (2025) | $4.74 |
|---|---|
| Revenue | $455.64M |
| Revenue Growth (YoY) | +28.70% |
| Gross Profit | $455.64M |
| Operating Income | $210.67M |
| Pretax Income | $694.81M |
| Net Income | $696.13M |
| EBITDA | $879.25M |
| EBIT | $780.93M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 64.51% of the $3.24B in total assets.
| Cash and Equivalents | $46.56M |
|---|---|
| Total Debt | $1.04B |
| Net Debt | $993.77M |
| Net Debt Per Share | $20.27 |
| Working Capital | -$44.73M |
| Shareholder Equity | $2.09B |
| Book Value Per Share | $42.62 |
| Total Assets | $3.24B |
| Total Liabilities | $1.14B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $391.00M of capital spending, operating cash flow left -$156.88M of free cash flow.
| Operating Cash Flow | $234.12M |
|---|---|
| Capital Expenditures | $391.00M |
| Free Cash Flow | -$156.88M |
| FCF Per Share | -$3.19 |
| Depreciation and Amortization | $100.02M |
| Dividends Paid | $178.61M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 46.24%, against a 5-year average of 42.09%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | 46.24% |
| Pretax Margin | 152.49% |
| Net Margin | 152.78% |
| EBITDA Margin | 192.97% |
| EBIT Margin | 171.39% |
| FCF Margin | -34.43% |
| Operating Margin (5Y Average) | 42.09% |
| Net Margin (5Y Average) | 35.82% |
Growth
FFO per share grew 1.00% a year over 3 years, and revenue 7.01% a year.
| FFO Per Share Growth (3Y CAGR) | +1.00% |
|---|---|
| Revenue Growth (3Y CAGR) | +7.01% |
| Revenue Growth (5Y CAGR) | +2.45% |
| EPS Growth (3Y CAGR) | +20.74% |
| EPS Growth (5Y CAGR) | -1.50% |
| Operating Income Growth (3Y CAGR) | +44.22% |
| Book Value Per Share Growth (2Y CAGR) | +5.78% |
| Tangible Book Per Share Growth (2Y CAGR) | +5.78% |
Dividends and Yields
NHI pays out 79.32% of 2025 FFO as dividends.
| Dividend Per Share (Annual) | $3.76 |
|---|---|
| Dividend Yield | 6.26% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +0.37% |
| Dividend Growth (5Y CAGR) | -3.77% |
| Payout Ratio (2025 FFO) | 79.32% |
| FFO Yield (2025) | 7.90% |
| FCF Yield | -5.33% |
| Buyback Yield | -3.15% |
| Shareholder Yield | 2.92% |
Peer Position
Against 12 similar companies, NHI has the 5th highest P/FFO and the 3rd highest P/S.
P/FFOPeer median 11.0x
P/S RatioPeer median 4.9x
ROICPeer median 4.25%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +10.13%
Dividend YieldPeer median 5.87%
| P/FFO | 12.1x vs 11.0x median |
|---|---|
| P/S Ratio | 6.5x vs 4.9x median |
| ROIC | 19.71% vs 4.25% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +28.70% vs +10.13% median |
| Dividend Yield | 6.26% vs 5.87% median |
Analyst Forecast
FFO per share estimates imply 4.64% growth a year over the next 2 years. Consensus estimates put revenue growth at 13.66% a year over the next 2 fiscal years.
| FFO Per Share Growth Forecast (2Y CAGR) | +4.64% |
|---|---|
| Revenue Growth Forecast (2Y CAGR) | +13.66% |
| EPS Growth Forecast (2Y CAGR) | -6.28% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NHI
What is NHI's market cap?
National Health Investors has a market cap of $2.98B. Its enterprise value, which adds debt and subtracts cash, is $3.98B.
What is NHI's price to FFO ratio?
National Health Investors has a P/FFO of 12.1x on its 2026 FFO estimate.
How many shares of NHI are outstanding?
National Health Investors has 49.04M shares outstanding. The count is up 3.38% from a year earlier.
Does NHI pay a dividend?
Yes. National Health Investors pays $3.76 a share a year, a dividend yield of 6.26%.
How much debt does NHI have?
National Health Investors has $1.04B of total debt and $46.56M of cash and equivalents, a net debt position of $993.77M.
NHI pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors